Monitoring How Tumors Respond to Treatment with ctDNA
Erica Tennenhouse, PhD | May 5, 2021
ctDNA assays can facilitate tracking of a tumor's response to treatment over time
liquid biopsy
New Liquid Biopsy IDs Lymph Node Metastasis in Early-Stage T1 Colorectal Cancer
City of Hope | April 27, 2021
The new, blood-based test could help people with non-high-risk early-stage colorectal cancer avoid unnecessary surgery
Liquid Biopsies Offer Quicker, Easier Lung Cancer Testing
Pat Carragher, Endeavor, Moffitt Cancer Center | January 8, 2021
A new liquid biopsy test uses next-generation sequencing to identify specific mutations in NSCLC
The Key to Increased Sensitivity in Liquid Biopsy
Erica Tennenhouse, PhD | October 27, 2020
Higher conversion increases data quality and accuracy of results
The Power of Predictive Biomarkers
George Karlin-Neumann, PhD | July 21, 2020
ddPCR-based liquid biopsies can provide reliable and timely biomarker information to help guide treatment decisions
The Need for Standardization in Liquid Biopsy Sample Prep
Catherine Crawford-Brown, MSc | June 4, 2020
Reproducible workflows would help clinical labs successfully and routinely perform liquid biopsy assays
Microfluidic Technology for Cancer Diagnosis
Clinical Lab Manager | June 1, 2020
Exploring some of the microfluidic technologies used for cancer diagnosis
Blood Test May Help Doctors Catch Pancreatic Cancer Early
University of Pennsylvania School of Medicine | April 16, 2020
Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging
A Liquid Biopsy Test Can Identify Patients Who May Respond to Immune Checkpoint Blockade
American Association for Cancer Research | September 10, 2019
Further research, conducted across a broader range of tumor types, will be necessary to confirm the study results
Experimental Noninvasive Tool Monitors Effectiveness of Stem Cell Transplantation
University of Maryland School of Medicine | May 23, 2019
Potential of transplanted stem cell secretions as a liquid biopsy